These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20503148)
1. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios. Tanum L; Strand LP; Refsum H Pharmacopsychiatry; 2010 Jul; 43(5):190-3. PubMed ID: 20503148 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective HPLC-assay for citalopram and its metabolites. Zheng Z; Jamour M; Klotz U Ther Drug Monit; 2000 Apr; 22(2):219-24. PubMed ID: 10774637 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997. Reis M; Lundmark J; Bengtsson F Ther Drug Monit; 2003 Apr; 25(2):183-91. PubMed ID: 12657912 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective single-dose kinetics of citalopram and its metabolites in rats. Kugelberg FC; Carlsson B; Ahlner J; Bengtsson F Chirality; 2003 Aug; 15(7):622-9. PubMed ID: 12840828 [TBL] [Abstract][Full Text] [Related]
5. Analytical methodologies for the enantiodetermination of citalopram and its metabolites. Budău M; Hancu G; Rusu A; Muntean DL Chirality; 2020 Jan; 32(1):32-41. PubMed ID: 31702071 [TBL] [Abstract][Full Text] [Related]
6. On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma. Results compared with solid-phase extraction methodology. Ohman D; Carlsson B; Norlander B J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):365-73. PubMed ID: 11334352 [TBL] [Abstract][Full Text] [Related]
7. In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats. Kugelberg FC; Apelqvist G; Carlsson B; Ahlner J; Bengtsson F Br J Pharmacol; 2001 Apr; 132(8):1683-90. PubMed ID: 11309239 [TBL] [Abstract][Full Text] [Related]
8. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC. Rochat B; Amey M; Van Gelderen H; Testa B; Baumann P Chirality; 1995; 7(6):389-95. PubMed ID: 7577348 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. Kosel M; Eap CB; Amey M; Baumann P J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):234-8. PubMed ID: 9869386 [TBL] [Abstract][Full Text] [Related]
10. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study. Berzas-Nevado JJ; Villaseñor-Llerena MJ; Guiberteau-Cabanillas C; Rodríguez-Robledo V Electrophoresis; 2006 Feb; 27(4):905-17. PubMed ID: 16470634 [TBL] [Abstract][Full Text] [Related]
11. Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram. Le Bloc'h Y; Woggon B; Weissenrieder H; Brawand-Amey M; Spagnoli J; Eap CB; Baumann P Ther Drug Monit; 2003 Oct; 25(5):600-8. PubMed ID: 14508384 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic consequences of a citalopram treatment discontinuation. Voirol P; Rubin C; Bryois C; Kosel M; Buclin T; Baumann P Ther Drug Monit; 1999 Jun; 21(3):263-6. PubMed ID: 10365634 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of citalopram enantiomers and metabolites in elderly patients. Foglia JP; Pollock BG; Kirshner MA; Rosen J; Sweet R; Mulsant B Psychopharmacol Bull; 1997; 33(1):109-12. PubMed ID: 9133760 [TBL] [Abstract][Full Text] [Related]
15. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005 [TBL] [Abstract][Full Text] [Related]
16. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography. Rochat B; Amey M; Baumann P Ther Drug Monit; 1995 Jun; 17(3):273-9. PubMed ID: 7624924 [TBL] [Abstract][Full Text] [Related]
17. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites. Unceta N; Goicolea MA; Barrio RJ Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412 [TBL] [Abstract][Full Text] [Related]
18. Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study. Nikisch G; Eap CB; Baumann P Pharmacol Res; 2008; 58(5-6):344-7. PubMed ID: 18940259 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting. Reis M; Olsson G; Carlsson B; Lundmark J; Dahl ML; Wålinder J; Ahlner J; Bengtsson F J Clin Psychopharmacol; 2002 Aug; 22(4):406-13. PubMed ID: 12172341 [TBL] [Abstract][Full Text] [Related]
20. Enantioselective analysis of citalopram and demethylcitalopram in human whole blood by chiral LC-MS/MS and application in forensic cases. Johansen SS Drug Test Anal; 2017 Oct; 9(10):1549-1554. PubMed ID: 28178765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]